[Scleromyxedema therapy with isotretinoin].
We report on a 56-year-old male patient suffering from scleromyxedema, who was successfully treated with isotretinoin (13-cis retinoic acid, Roaccutan). After 10 months therapy, we observed considerable reduction of the cutaneous infiltration and the skin thickening; the papular eruptions had almost completely disappeared. The mobility of the joints, however, could only be slightly improved.
Lominska-Lasota
K
K
Universitäts-Hautklinik und Poliklinik, der Rheinischen Friedrich-Wilhelm-Universität Bonn.
Rosen-Uzelac
G
G
Reichl
W
W
Bauer
R
R
D004334:Drug Administration Schedule; D006801:Humans; D015474:Isotretinoin; D008297:Male; D008875:Middle Aged; D009230:Myxedema / Q000188:drug therapy* / Q000473:pathology; D012594:Scleroderma, Localized / Q000188:drug therapy* / Q000473:pathology; D012867:Skin / Q000473:pathology; D014212:Tretinoin / Q000008:administration & dosage*
D014212:Tretinoin; D015474:Isotretinoin
Skleromyxödem-Therapie mit Isotretinoin.